Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04808245
Title A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas (INTERCEPT-H3)
Acronym INTERCEPT-H3
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors German Cancer Research Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
University Medical Center Mannheim, Department of Neurology RECRUITING Mannheim Baden-Wuerttemberg 68167 Germany Details
University Clinic Tuebingen, Neurological Clinic, Department of Neurology RECRUITING Tuebingen Baden-Wuerttemberg 72076 Germany Details
Department of Neurology and Polyclinic, Universitiy Clinic Heidelberg NOT_YET_RECRUITING Heidelberg Baden-Württemberg 69120 Germany Details
Dr. Senckenberg Institute for Neurooncology, University Hospital Frankfurt NOT_YET_RECRUITING Frankfurt am Main Hessen 60528 Germany Details
Clinical Neuro-Oncology Section, University Hospital Bonn (UKB) NOT_YET_RECRUITING Bonn Nordrhein-Westfalen 53127 Germany Details
Neurooncology Department, University Hospital Essen NOT_YET_RECRUITING Essen Nordrhein-Westfalen 45147 Germany Details
Clinic and Polyclinic for Neurosurgery, University Hospital Carl Gustav Carus Dresden NOT_YET_RECRUITING Dresden Sachsen 1307 Germany Details
Department of Neurosurgery with Pediatric Neurosurgery NOT_YET_RECRUITING Berlin 10117 Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field